Projekt
A multicenter, double-blind, placebo-controlled phase 3 study to demonstrate the efficacy and safety of ACT-293987 in patients with pulmonary arterial hypertension
Abgebrochen · 2009 bis 2013
Burger Barbara, Haider Karin, Rüdiger Jochen, Brutsche Martin
Art
Reichweite
Bereiche
Status
Start
Ende
Finanzierungsart
Studiendesign
Kurzbeschreibung/Zielsetzung
The primary objective is to demonstrate the effect of ACT-293987 on time to first clinical worsening in patients with pulmonary arterial hypertension (PAH)